One sentence summary: Molecular cloning, expression and kinetic analysis of the native Campylobacter jejuni enzyme and the cysteine 176 to serine variant. Editor: LÃgia Saraiva
INTRODUCTION
Campylobacter jejuni has been classified as an emerging antibiotic-resistant pathogen worldwide (Johnson, Shank and Johnson 2017) , where nearly 1% of Europe's population is infected, and the percentage is expected to be higher in developing countries (Epps et al. 2013) . Campylobacter jejuni is commonly present in the gastrointestinal tract (GIT) of chickens, and can be transmitted to humans via contaminated food and/or water (Liu et al. 2012) . In infants, C. jejuni infection causes severe diarrhea in 6-12% of cases and diarrhea is the second leading cause of mortality in children worldwide (Liu et al. 2016) . Campylobacter infection may also be detrimental to children as it is suggested to be an important contributor to growth deficits, especially in low-resource settings (Amour et al. 2016) . Due to the increased antibiotic resistance of C. jejuni and the impact on human health, specifically infants and children, physiological understanding of C. jejuni and development of new therapeutic strategies are crucial.
Aside from gastroenteritis infections, pathogens like C. jejuni have been attributed to methemoglobinemia, a disease primarily found in infants where methemoglobin is produced (Powlson et al. 2008) . Methemoglobinemia has also been linked to well water with high concentrations of nitrate (Knobeloch et al. 2000) . Re-evaluation of these studies indicates that the cases of incidence occurred with well water that was contaminated with feces (Powlson et al. 2008) . Due to fecal contamination, the water contained appreciable amounts of bacterial pathogens such as C. jejuni as well as nitrate, implying methemoglobinemia may be induced by bacterial nitrate reduction producing NO that converts hemoglobin to methemoglobin. The nitrate reduction by C. jejuni has not been fully investigated despite a potential correlation between excess nitrate in well water, the presence of C. jejuni and methemoglobinemia. Therefore, there is a need to understand nitrate reduction in C. jejuni at the molecular level.
Bacterial nitrate reduction is catalyzed by a class of pterincontaining molybdenum enzymes called nitrate reductase. There are three subclasses of prokaryotic nitrate reductases: periplasmic (Nap), respiratory (Nar) and assimilatory (Nas) (Stolz and Basu 2002) . Of these, C. jejuni only harbors the genes for Nap (Pearson et al. 2007) . Nap is a dissimilatory enzyme complex, i.e. it is a catabolic complex that reduces nitrate. When Nap is coupled to the oxidation of formate or NADH, a proton gradient is generated enabling the production of ATP. Moreover, Nap can generate energy through nitrate respiration as part of the denitrification and dissimilatory nitrate reduction to ammonia pathways in bacteria (Stolz and Basu 2002; Sparacino-Watkins, Stolz and Basu 2014) .
Unlike many pathogens, C. jejuni has no defining toxins and relies on other mechanisms for infection (Crofts et al. 2018) . The key metabolic pathways, like nitrate metabolism, that boost colonization may be one such mechanism. To this end, the oxidation of various electron donors such as FADH 2 , H 2 , formate, lactate or succinate can be coupled with nitrate (NO 3 − ) reduction.
Succinate is readily available in the host's GIT (Hofreuter 2014) where NO 3 − reduction has been recognized as an influential factor during C. jejuni host colonization (Weingarten, Grimes and Olson 2008; Liu et al. 2012) . Under inflammatory conditions the concentration of formate is increased and formate oxidation has been shown to be influenced by elevated nitrate levels (Hughes et al. 2017) . During colonization in chickens, C. jejuni induces expression of the napAGHBLD operon (Woodall et al. 2005 ) and during C. jejuni infection of mammalian cells, the expression of the catalytic subunit, NapA, is increased. (Liu et al. 2012 ) A napA deletion decreased the adhesion of C. jejuni to human INT-407 cells and impacted motility and biofilm formation (Kassem et al. 2012) . Recently, Nap has been shown to be important in the pathogenesis of the intestinal pathogen Salmonella typhimurium that is also passed by poultry reservoirs to humans (Lopez et al. 2015) . It has been demonstrated that a NapA deletion reduces the ability to infect host cells signifying Nap influences pathogenesis (Lopez et al. 2015) . This result may indicate a common mechanism for intestinal pathogen survival via nitrate respiration using Nap.
Campylobacter jejuni NapA has not been biochemically characterized despite the significance of NO 3 − reduction by this pathogen. It has also been reported that there is a potential use of nitrate reductase genes for differentiating Campylobacter species (Miller et al. 2007) . Given the paucity of biochemical characterization of C. jejuni, fundamental information to understand nitrate reduction by C. jejuni is lacking. Here we report the cloning of napA, heterologous expression, and biochemical characterization of recombinant NapA (from here on referred to as the native enzyme). Using the expression system we have exchanged C176 (that putatively coordinates the molybdenum center) to serine. This variant has also been purified and biochemically characterized. In addition, we also compared the kinetic results with previously isolated NapA assayed by methyl viologen in solution.
MATERIALS AND METHODS
Plasmids and oligonucleotides are listed in Table S1 (supplementary material). Chromosomal DNA from the pathogenic C. jejuni strain RM1221 was used as the source of napA, napL and napD. Polymerase chain reaction (PCR) was used to amplify napLD maturation genes (YP 178877 and YP 178878) and the DNA fragment was inserted into the pTZS7R/T TA cloning vector (Thermo Fisher) yielding plasmid pBM8A. The napLD genes were excised using NcoI and EcoRI and then inserted into the pRSFDuet-1 expression vector (Novagen) to yield plasmid pBM9A.The napA gene (YP 178873) was amplified using PCR and the restriction enzyme-digested fragment was inserted into the pMCSG32 vector (DNASU) using NdeI and XmaI upstream from the TEV cleavable C-terminal hexa-histidine coding sequence, yielding the pMCSG32 napA plasmid. The napA gene was excised with NdeI and XhoI taking the tagged gene and inserting it into the same sites of pBM9A containing the maturation genes napLD to yield plasmid pBM10C. Thus, pBM10C allows coexpression of his tagged napA with untagged napLD in Escherichia coli from separate T7 promoters. All DNA constructs were confirmed by sequencing (ACGT Inc). Escherichia coli K12 (New England Biolabs Shuffle T7 lysY #C3027) cells containing the pBM10C plasmid were maintained on LB medium supplemented with 30 μg/mL kanamycin. Inoculated cultures were grown overnight at 37
• C, then transferred to 1 L of fresh autoinduction medium containing 12 g/L peptone, 24 g/L yeast extract, 1 g/L glucose, 2 g/L lactose, 0.50% (v/v) glycerol and 90 mM potassium phosphate buffer pH 7.00. The cultures were supplemented with kanamycin (30 μg/mL), Na 2 MoO 4 (1 mM) and FeSO 4 (0.5 mM), then incubated at room temperature for 48 h. NapA (104 kDa) expression was induced by the lactose present in the medium. Expression was conducted at room temperature for 48 h while shaking. Cells were collected by centrifugation at 4400 × g at 4
• C. The cell pellet was resuspended in ice cold buffer containing 50 mM HEPES, 300 mM sodium chloride and 10 mM imidazole at pH 7.00. Cells were lysed by ultrasonication using 30-s pulses in 45-s intervals over 10 min in an ice bath. The lysate was centrifuged at 7100 × g for 1 h at 4
• C. The soluble fraction was loaded on a HisTrap HP 5 mL prepacked column (GE Life Sciences), and separation was conducted with anÄKTA Prime Plus (GE Life Sciences) system. The column was washed with a step gradient of 20 and 50 mM imidazole. NapA was eluted with 250 mM imidazole. The fractions were pooled and concentrated during buffer exchange to 50 mM HEPES pH 7.00 using 30 kDa cutoff centrifugal filters (Millipore). The concentrated protein was loaded onto a HiPrep 16/60 Sephacryl S-200 size exclusion column (GE Healthcare). The resulting NapA fractions were pooled, concentrated and stored in buffer containing 50 mM HEPES pH 7.00 at -80 • C. SDS-PAGE was used to screen fractions for NapA content and purity using standard protocols. Mutagenesis of C. jejuni napA was conducted using the QuikChange II Site-Directed Mutagenesis Kit (Qiagen) with the pBM10C plasmid as template. The primers designed for a napA-C176S mutation are listed in Table S1 (Supporting Information). The PCR product was sequenced at ACGT Inc. The resulting plasmid, pBM10C-C176S, was expressed in E. coli, and NapA-C176S was purified in the same manner as the native NapA.
Nitrate reductase activity was measured spectrophotometrically by monitoring oxidation of reduced methyl viologen at 630 nm. Methyl viologen was reduced electrochemically in an inert atmosphere glovebox using a Metrohm PGASTAT204 potentiostat in a three electrode system with an Ag/AgCl reference electrode, a platinum wire auxiliary electrode and platinum mesh as the working electrode. The potential was held at -500 mV vs SHE (midpoint potential of methyl viologen is -449 mV vs SHE at pH 7.00; Watanabe and Honda 1982) until methyl viologen was reduced. Assays were conducted in an inert atmosphere glove box at 25
• C using a Bio-Tek ELx808 Absorbance Microplate Reader. Assays were conducted with a total reaction volume of 300 μL. Nitrate addition initiated the reaction which was monitored for 5 min (NapA) or 15 min (NapA-C176S). The rate of methyl viologen oxidation was calculated using the BeerLambert law given the extinction coefficient of reduced methyl viologen (7800 M −1 cm −1 at 630 nm). These rates were analyzed with a non-linear Michaelis-Menten model using OriginPro 2018 (OriginLab Inc.). Protein concentrations were determined using the Coomassie protein assay kit (Thermo Scientific) with bovine serum albumin standard (Pierce).
RESULTS
The napALD genes were coexpressed resulting in the production of recombinant NapA protein with the original C. jejuni Nterminal twin arginine translocase (TAT) leader sequence intact to preserve the NapA chaperone interactions. The napA gene contained a polyhistidine tag at the C-terminus that was kept intact for this investigation. NapA-hexaHis (hereafter referred to as NapA) was isolated by immobilized metal chromatography and purified to 95% homogeneity (Fig. 1A) . The identity of the purified ∼100 kDa protein was confirmed to be NapA from C. jejuni by liquid chromatography-mass spectrometry (LC-MS). The UV-Vis spectrum of C. jejuni NapA (Fig. 1C) shows a band at 400 nm similar to the band observed in the spectrum of Desulfovibrio desulfuricans NapA, indicating the presence of a [4Fe4S] cluster (Bursakov et al. 1995) . The metal (Mo and Fe) content in the enzyme was determined by inductively coupled plasma mass spectrometry (ICP-MS). The metal analyses indicate 92% Mo incorporation in active C. jejuni NapA. The Fe:Mo ratio was slightly higher than the theoretical value of 4:1 suggesting complete iron incorporation. (Table S2 , Supporting Information)
Campylobacter jejuni NapA displays Michaelis-Menten kinetics (Fig. 2) with those reported for other characterized NapA (Table 1) reveals important differences in the kinetic properties. The major difference is the low K M of the heterologously produced C. jejuni NapA which indicates a high binding affinity for NO 3 − .
A three-dimensional model of the C. jejuni NapA structure was created using the structure of Rhodobacter sphaeroides NapA as the template (Sparacino-Watkins, Stolz and Basu 2014). The electrostatic potential was calculated for C. jejuni NapA, and, for comparison, the R. sphaeroides, D. desulfuricans and E. coli NapA structures (Fig. 3) . In all structures, a dense region of positive charge is localized in the active site funnel, possibly used to facilitate the transport of NO 3 − into the cavity for catalytic transformation. The homology model (SparacinoWatkins, Stolz and Basu 2014) suggests the substrate channel and catalytic pocket are more basic than other NapA proteins, which may influence the substrate binding as well as product release.
Based on the homology model of C. jejuni NapA and the protein sequence alignment (Fig. S1 , Supporting Information), we predicted that a strictly conserved cysteine at position 176 (C176), modeled in Fig. 3 (Sparacino-Watkins, Stolz and Basu 2014) , is likely to coordinate the molybdenum center in C. jejuni. We hypothesize that a C176S mutation would reduce the catalytic activity of the enzyme. Similar mutations have been reported for related molybdenum enzymes including sulfite oxidase (coordinating Cys to Ser/Ala), biotin sulfoxide reductase (coordinating Ser to Cys/Ala/Thr), DMSO reductase (coordinating Ser to Cys/Ala/His), Nas (coordinating Cys to Ala) and Nap (coordinating Cys to Ser) (Garde, Kinghorn and Tomsett 1995; Garrett and Rajagopalan 1996; Trieber et al. 1996; Hilton, Temple and Rajagopalan 1999; Pollock and Barber 2000; Hettmann et al. 2004; Qiu et al. 2010 ). These variants reduced or completely abolished activity compared to the native enzyme but there are no reports of determined rate constants (k cat or K M ) ( Table 2) .
The NapA-C176S variant was observed to be pure to 97% homogeneity via SDS-PAGE (Fig. 1B) . The identity of NapA and the presence of C176S substitution were confirmed by LC-MS (Fig. S2 , Supporting Information) and metal content was determined by ICP-MS (Table S2 , Supporting Information). Kinetic experiments with NapA-C176S indicated that this variant was active in reducing NO 3 − as a substrate but had significantly lower activity when compared to the native enzyme (Fig. 2) . This mutation increased the K M (307 ± 16 μM) and reduced the k cat (0.045 ± 0.001 s −1 )
by two orders of magnitude. Sadana and McElroy (1957) a Values calculated from kinetic parameters using the reported protein concentrations. et al. (2004) a Activity is indistinguishable from background, calculated from reported specific activity.
SO, sulfite oxidase; DMSOR, dimethyl sulfoxide reductase; BSOR, biotin sulfoxide reductase; Nas, assimilatory nitrate reductase; Nap, periplasmic nitrate reductase.
DISCUSSION
NapA has been isolated from native organisms as a heterodimer with the diheme c-type cytochrome NapB, from E. coli (Jepson et al. 2007) , R. sphaeroides (Arnoux et al. 2003) , Achromobacter fischeri (Sadana and McElroy 1957) , Cupriavidus necator (Coelho et al. 2007) and Thiosphaera pantotropha (Berks et al. 1994) , or as a monomer from D. desulfuricans (Bursakov et al. 1995) . Whether the Nap is monomeric or heterodimeric depends on its ability to form salt bridges at the NapA:NapB interface (Simpson, McKinzie and Codd 2010) . Two residues E76 and S801 (in R. sphareoides, Rs; Fig. S1 , Supporting Information) have been identified as critical for the formation of the NapAB heterodimer (Simpson, McKinzie and Codd 2010) . The sequence alignment of C. jejuni NapA with R. sphaeroides NapA shows the presence of a proline (P70) instead of a critical glutamate precluding the formation of the salt bridge, and thus C. jejuni NapA was expected to be a monomer in solution. Escherichia coli NapA also contains this proline substitution, and Jepson et al. (2007) reported that although NapA and NapB interact, the NapAB complex is not tight and the subunits purify independently. NapA representatives from each class of gram-negative Proteobacteria have been isolated except the Epsilonproteobacteria. The class of Epsilonproteobacteria includes notable human pathogens like Helicobacter and Campylobacter species. To date, this is the first active epsilonproteobacterial NapA to be isolated and have its enzymatic properties explored. Successful heterologous production of a metalloprotein often requires the coexpression of genes encoding dedicated chaperones to ensure proper folding and metal center insertion. Expression of Pseudomonas strain G-179 NapA in E. coli, without the cognate maturation proteins, resulted in non-functional NapA found in inclusion bodies (Bedzyk, Wang and Ye 1999) . Genetic experiments with Wolinella succinogenes show napL and napD to be critical for full activity in a similar Nap system (Kern, Mager and Simon 2007) . These studies emphasize the importance of maturation proteins in obtaining functional enzyme. To maximize heterologous production of active NapA containing both a molybdenum cofactor and a [4Fe4S] cluster, the maturation proteins NapL and NapD were coexpressed in this study. In addition, the TAT leader sequence on NapA was not modified to preserve the possible interactions with these maturation proteins. The C. jejuni TAT sequence varies from the E. coli sequence (Fig.  S1 , Supporting Information); however, pure active enzyme was isolated despite this difference. The UV-Vis spectrum (Fig. 1C) is indicative of the iron-sulfur cluster, which is supported by the ICP-MS data. Furthermore, the high molybdenum incorporation confirms an effective expression system for active C. jejuni NapA has been achieved. To our knowledge, this represents the first example of a heterologously expressed functional periplasmic nitrate reductase.
The data presented here reveal that C. jejuni NapA is a very efficient NO 3 − reducing enzyme with a high k cat /K M value and low K M . The low K M indicates a high binding affinity for NO 3 − (Table 1) , which is consistent with the electrostatic potential calculations ( Fig. 3 ) (Sparacino-Watkins, Stolz and Basu 2014) . The low K M could prove useful to the pathogen when competing for nitrate with the commensal nitrate utilizing organisms of the host microflora. Nitrate metabolism has been positively associated with colonization by Salmonella (Lopez et al. 2015) , E. coli (Winter et al. 2013) and C. jejuni (Kassem et al. 2012) . Both solution-based assay and protein film voltammetry (PFV) have been used in understanding the kinetic properties of Nap, although they exhibit some differences. For example, R. sphaeroides NapAB has a reported K M of 7.50 μM, which is comparable to the C. jejuni NapA K M of 3.40 μM (Frangioni et al. 2004) . Interestingly, Bertrand et al. (2007) argued the K M measured in solution assays potentially depends on all rates in the catalytic cycle and will depart from K M determined by PFV, if intermolecular electron transfer is the rate determining step in solution assays. The K M values determined in solution may be higher than those determined by PFV. For this reason, we only discuss solutionbased parameters obtained by using reduced methyl viologen as an electron donor (Table 1) .
Compared to other Nap proteins in Table 1 , C. jejuni NapA has the second highest substrate affinity, second only to Magnetospirillum magnetotacticum. Interestingly, M. magnetotacticum prefers microaerobic environments like C. jejuni (Maratea and Blakemore 1981) . Although M. magnetotacticum is not known to be pathogenic, its nap operon does appear to be phylogenetically closer to C. jejuni nap than its fellow α-proteobacteria (SparacinoWatkins, Stolz and Basu 2014) . Furthermore, C. jejuni NapA appears to be a more efficient NO 3 − reducer than NapA from M. magnetotacticum as well as all other reported Nap proteins (Table 1) by approximately one order of magnitude in the k cat /K M . Although the k cat /K M is higher, k cat itself is lower than the homologously expressed Naps in Table 1 . A lower k cat may be attributable to substrate/product inhibition, attenuated electron transfer or conformational change. However, the exact reason for a lower k cat remains an open question. Campylobacter jejuni NapA is expected to and does exhibit a higher affinity towards NO 3 − . We suggest there is a higher affinity for NO 3 − by C. jejuni NapA because it encounters low concentrations of NO 3 − under physiological conditions (Winter et al. 2013; Lopez et al. 2015) . Although the inflammatory response increases nitrate concentration in the GIT of the host (Winter et al. 2013; Lopez et al. 2015; Hughes et al. 2017) , the concentration is below 1 mM (Winter et al. 2013; Lopez et al. 2015) . Nap is expressed maximally at 1 mM and does not express above 6 mM while Nar expresses maximally at 10 mM and does not express below 1 mM suggesting that Nap will be the primary nitrate reductase expressed at a low nitrate concentration (Wang, Tseng and Gunsalus 1999) . Therefore, a pathogen that uses Nap may have an advantage under these conditions and Nap may exhibit a high affinity for NO 3 − (Lopez et al. 2015) .
It has been suggested that Nap faces the periplasm and acts as a NO 3 − scavenger as Nap does not depend on NO 3 − transport (Simpson, Richardson and Codd 2010) . It is interesting that C. jejuni NapA has a higher binding affinity for NO 3 − (low K M ) and a higher efficiency for producing nitrite than the NapA proteins from the non-pathogenic microbes. Genetic experimentation suggests that NO 3 − metabolism is important in the physiology of C. jejuni (Woodall et al. 2005; Kassem et al. 2012; Liu et al. 2012) . The high efficiency of this enzyme compared to Nap proteins from non-pathogenic organisms suggests nitrate metabolism is important to this intestinal pathogen, but its role in pathogenicity is not completely clear. We suggest that NO 3 − is one of the metabolites or substrates that the pathogen relies on to ensure proper colonization into the gut of its host. We have successfully altered the Mo coordinating residue in NapA, cysteine 176, to serine (Fig. S2, Supporting Information) . The resulting variant is analogous to the coordination of Mo in DMSO reductase and trimethylamine N-oxide reductase (Li et al. 2000) . Similar alterations in other Mo enzymes show negligible or no activity (Table 2) . In these cases, steady-state kinetic parameters, K M and k cat, were not reported. We have conducted Michaelis Menten kinetics on the C. jejuni NapA-C176S variant. This variant can reduce nitrate; however, the efficiency is lowered by four orders of magnitude. Interestingly, the K M changed by two orders of magnitude suggesting the serine residue impacts substrate affinity as well. We suggest that the mutation could induce a rearrangement of the active site altering substrate access or by destabilizing a key interaction that assists in substrate docking. The overall reduction in the catalytic rate is also modulated by this mutation, possibly in part due to a change in redox potential of the Mo center. Such a change in the reduction potential has been observed in model complexes (Uhrhammer and Schultz 2004) .
In summary, C. jejuni NapA has been heterologously expressed in E. coli. To our knowledge, this is the first example of a functional NapA from an epsilonproteobacterium that has been overexpressed and purified. Kinetic analysis of C. jejuni NapA revealed a high substrate binding affinity and kinetic efficiency. The sequence alignment of NapA suggests C176 coordinates Mo.
